Last reviewed · How we verify

NCT05122832

Prevalence of NCD Risk Factors in Kazakhstan

Completed Last updated 14 March 2023
What this trial tests

trial testing Blood test in Non-Communicable Chronic Diseases in 20,400 participants. Completed in 20 August 2022.

Timeline
23 October 2021
Primary endpoint
20 August 2022
20 August 2022

Quick facts

Lead sponsorAsfendiyarov Kazakh National Medical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20,400
Start date23 October 2021
Primary completion20 August 2022
Estimated completion20 August 2022
Sites1 location across Kazakhstan

Drugs / interventions tested

Conditions studied

Sponsor

Asfendiyarov Kazakh National Medical University

Who can join

Adults 18 to 69, any sex, with Non-Communicable Chronic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cross-sectional study that aims to study the prevalence of risk factors of noncommunicable diseases in people aged 18 to 69 years using the standardized and adopted STEPS questionnaire in the Republic of Kazakhstan.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Assessment of hypercholesterolemia prevalence and its demographic variations in the Republic of Kazakhstan.
    Kulimbet M, Davletov K, Saliev T, Davletov D, et al · · 2024 · cited 6× · PMID 38531935 · DOI 10.1038/s41598-024-57884-4
  2. Evaluation of the sexual function of men in Kazakhstan during 2021-2022: A cross-sectional study.
    Sikhymbaev M, Ospanova D, Grzhibovsky A, Akkaliyev M, et al · · 2023 · cited 3× · PMID 36865526 · DOI 10.1002/hsr2.1142
  3. Sex differentials in the prevalence of behavioral risk factors and non-communicable diseases in adult populations of West Kazakhstan.
    Baspakova A, Abitova AZ, Mussin NM, Kaliyev AA, et al · · 2024 · cited 2× · PMID 38420037 · DOI 10.3389/fpubh.2024.1333887
  4. Prevalence of chronic kidney disease in Kazakhstan: evidence from a national cross-sectional study.
    Nursultanova L, Kabulbayev K, Ospanova D, Tazhiyeva A, et al · · 2023 · cited 1× · PMID 37679536 · DOI 10.1038/s41598-023-42031-2
  5. Association Between Socio-Demographic, Behavioural, and Health-Related Factors and Fruit, Vegetable, and Salt Consumption Among Adults Aged 18-69 Years in Kazakhstan: A Cross-Sectional Study.
    Shoranov M, Ibrayeva A, Alchinbayev M, Sadykov B, et al · · 2026 · PMID 41978204 · DOI 10.3390/nu18071154
  6. Physical Activity Levels in Kazakhstan: A Cross-Sectional Nationwide Study on Demographic, Socioeconomic, and Regional Factors.
    Ibrayeva A, Shoranov M, Muminov T, Ismoldayev Y, et al · · 2025 · PMID 41303750 · DOI 10.3390/medicina61111913
  7. Association between sociodemographic factors and alcohol consumption among adults aged 18-69 years in Kazakhstan: a cross-sectional study.
    Ibrayeva A, Shoranov M, Alchinbayev M, Ramazanova B, et al · · 2025 · PMID 40374232 · DOI 10.1136/bmjopen-2024-094508
  8. Prevalence and characteristics of tobacco use among adults in Kazakhstan: A cross-sectional National Survey.
    Ibrayeva A, Shoranov M, Aipov R, Katarbayev A, et al · · 2025 · PMID 40129755 · DOI 10.1016/j.gloepi.2025.100194

Verify or expand the search:

Other trials of Blood test

Trials testing the same drug.

Other recruiting trials for Non-Communicable Chronic Diseases

Currently open trials in the same condition.

Other Asfendiyarov Kazakh National Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05122832.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing